Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Psoralen and Isopsoralen from Psoralea corylifolia Suppress NSCLC by Dual Mechanisms: STAT3 Inhibition and ROS
Liwei Bi1,2,3, Guangyi Chen1, Wanfen Liu1
1Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China.
Abstract:
Background: Non-small cell lung carcinoma (NSCLC) is the most prevalent form of lung cancer, and its progression is closely associated with constitutive activation of signal transducer and activator of transcription 3 (STAT3). This study used surface plasmon resonance (SPR) technology to develop a STAT3-targeting recognition system and identify natural STAT3-targeting compounds from the traditional Chinese medicine Psoralea corylifolia and to evaluate their anti-NSCLC activities, with particular attention to reactive oxygen species (ROS) regulation. Methods: The SPR biosensor immobilized with STAT3 was used to screen and enrich STAT3-binding constituents of Psoralea corylifolia, and to determine ligand-STAT3 affinities. Molecular docking was performed to characterize interactions within the STAT3 SH2 domain. Functional effects were assessed in A549 cells using proliferation and scratch migration assays. Antioxidant capacity was evaluated via hydroxyl radical and superoxide anion scavenging assays, and intracellular ROS levels were measured in hydrogen peroxide (H2O2)-induced oxidative stress models in human umbilical vein endothelial cells (HUVECs) and A549 cells. Results: SPR analysis showed that psoralen and isopsoralen bind to STAT3, with equilibrium dissociation constants (KD) of 80.92 µM and 28.11 µM, respectively. Molecular docking further confirmed their interaction with the STAT3 SH2 domain. Both compounds inhibited A549 proliferation and reduced migration. Beyond direct STAT3 inhibition, both compounds demonstrated notable free radical scavenging activity. In a H2O2-induced oxidative stress model, pretreatment with psoralen or isopsoralen significantly reduced ROS levels in HUVECs, while increasing ROS accumulation in A549 lung cancer cells. Conclusions: This work identifies psoralen and isopsoralen as novel dual-function STAT3 inhibitors that exert anti-NSCLC effects through combined STAT3 suppression and context-dependent ROS modulation, and demonstrates the utility of SPR for screening bioactive natural products.
Insights
This study identifies psoralen and isopsoralen from traditional Chinese medicine as novel inhibitors of signal transducer and activator of transcription 3 (STAT3) for treating non-small cell lung carcinoma (NSCLC). These compounds combat NSCLC by suppressing STAT3 and modulating reactive oxygen species (ROS).
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Toxicology
- Natural Product Chemistry
Background:
- Non-small cell lung carcinoma (NSCLC) progression is linked to activated signal transducer and activator of transcription 3 (STAT3).
- Traditional Chinese medicine offers potential sources for novel anti-cancer compounds.
- Understanding STAT3's role in NSCLC necessitates identifying targeted natural products.
Purpose of the Study:
- To develop a STAT3-targeting recognition system using surface plasmon resonance (SPR).
- To identify natural STAT3 inhibitors from Psoralea corylifolia.
- To evaluate the anti-NSCLC activities and reactive oxygen species (ROS) regulatory effects of identified compounds.
Main Methods:
- Utilized SPR biosensors for screening and affinity determination of STAT3-binding compounds.
- Employed molecular docking to analyze STAT3 SH2 domain interactions.
- Assessed anti-proliferative and anti-migratory effects in A549 cells; evaluated antioxidant capacity and intracellular ROS levels in HUVECs and A549 cells.
Main Results:
- Psoralen and isopsoralen were identified as STAT3 binders with specific affinities.
- Both compounds inhibited NSCLC cell proliferation and migration.
- Psoralen and isopsoralen exhibited antioxidant activity and modulated ROS levels differently in normal and cancer cells.
Conclusions:
- Psoralen and isopsoralen are novel dual-function STAT3 inhibitors with anti-NSCLC potential.
- Their efficacy stems from combined STAT3 suppression and context-dependent ROS modulation.
- SPR technology is effective for screening bioactive natural products targeting specific proteins like STAT3.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway